The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-((dimethylamino)methyl)phenyl)-2-(diphenylmethylene)hydrazinecarboxamide ID: ALA4521646
PubChem CID: 155542632
Max Phase: Preclinical
Molecular Formula: C23H24N4O
Molecular Weight: 372.47
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)Cc1ccc(NC(=O)NN=C(c2ccccc2)c2ccccc2)cc1
Standard InChI: InChI=1S/C23H24N4O/c1-27(2)17-18-13-15-21(16-14-18)24-23(28)26-25-22(19-9-5-3-6-10-19)20-11-7-4-8-12-20/h3-16H,17H2,1-2H3,(H2,24,26,28)
Standard InChI Key: CZDDIBMYNNZCII-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
40.5206 -9.4284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2290 -9.8359 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.9361 -9.4262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.6444 -9.8337 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.9348 -8.6090 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.3515 -9.4240 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
44.0598 -9.8315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.7669 -9.4218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.4724 -9.8294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.1790 -9.4204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.1781 -8.6024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.4648 -8.1950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.7611 -8.6064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.0611 -10.6487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5216 -8.6120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8141 -8.2046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1061 -8.6143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1100 -9.4358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8181 -9.8395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3972 -8.2078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6906 -8.6184 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.9818 -8.2119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6930 -9.4356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.3527 -11.0573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.3536 -11.8738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.0625 -12.2821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.7719 -11.8680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.7675 -11.0529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
3 5 2 0
4 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
7 14 1 0
1 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 1 1 0
17 20 1 0
20 21 1 0
21 22 1 0
21 23 1 0
14 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 14 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 372.47Molecular Weight (Monoisotopic): 372.1950AlogP: 4.32#Rotatable Bonds: 6Polar Surface Area: 56.73Molecular Species: BASEHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.10CX Basic pKa: 8.71CX LogP: 4.70CX LogD: 3.37Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.50Np Likeness Score: -1.29
References 1. Ma J, Ni X, Gao Y, Huang K, Liu J, Wang Y, Chen R, Wang C.. (2019) Identification and biological evaluation of novel benzothiazole derivatives bearing a pyridine-semicarbazone moiety as apoptosis inducers via activation of procaspase-3 to caspase-3., 10 (3): [PMID:31015910 ] [10.1039/C8MD00624E ]